Adeza files suit seeking to end fFN assay distribution pact with Matria.
This article was originally published in The Gray Sheet
Executive Summary
ADEZA SEEKS TO TERMINATE fFN ELISA TEST DISTRIBUTION PACT WITH MATRIA in a lawsuit filed March 10 in the Superior Court of Santa Clara, California. Sunnyvale, California-based Adeza Biomedical claims that Matria Healthcare "elected to delay and reduce the marketing of Adeza's products" and has not made its "best efforts" to promote Adeza's fetal fibronectin immunoassay test because it feared sales of the test could reduce demand for Matria's own products, such as its Home Uterine Activity Monitor (HUAM).